Design, synthesis, and biological evaluation of a series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as dual inhibitors of human immunodeficiency virus type 1 integrase and the reverse transcriptase RNase H domain. [electronic resource]
- Journal of medicinal chemistry Dec 2008
- 7717-30 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1520-4804
10.1021/jm8007085 doi
Antiviral Agents--chemistry Catalysis Catalytic Domain Cell Line Chemistry, Pharmaceutical--methods Drug Design HIV-1--enzymology Humans Hydrogen Bonding Inhibitory Concentration 50 Isoquinolines--pharmacology Models, Chemical Reverse Transcriptase Inhibitors--chemistry Ribonuclease H--chemistry